Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm

Journal of Vascular Surgery

Volumn 38, Issue 6, 2003, Pages 1363-1367

  Jones, Gregory T ^a,b   Phillips, Victoria L ^a,b   Harris, Eugenie L ^a,b   Rossaak, Jeremy I ^a,b   Van Rij, André M ^a,b  

^a University of Otago ^*

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN; GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALLELE; ANEURYSM; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

EID: 0344305386     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)01027-9     Document Type: Article

References (29)

1. Rossaak JI, Hill TM, Jones GT, et al. Familial abdominal aortic aneurysms in the Otago region of New Zealnd. Crdiovasc Surg 2001;9:241-8.
2. Tilson MD, Seashore MR. Human genetics of the abdominal aortic aneurysm. Surg Gynecol Obstet 1984;158:129-32.
3. Verloes A, Sakalihasan N, Koulischer L, et al. Aneuryms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 1995;21:646-55.
4. Rossaak JI, van Rij AM, Jones GT, et al. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. J Vasc Surg 2000;31:1026-32.
5. Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci (Lond) 1991;81:233-9.
6. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99:1788-94.
7. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
8. Hovsepian DM, Ziporin SJ, Sakurai MK, et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000;11:1345-52.
9. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:157-74.
10. Newman KM, Ogara Y, Malon AM, et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 1994;14:1315-20.
11. Brown DL, Hibbs MS, Kearney M, et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-31.
12. Palombo D, Maione M, Cifiello BI, et al. Matrix metalloproteinases: their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino) 1999;40:257-60.
13. Armstrong PJ, Johanning JM, Calton WC Jr, et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 2002;35:346-55.
14. McMillan WD, Patterson BK, Keen RR, et al. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 1995;15:1139-44.
15. Yamashita A, Noma T, Nakazawa A, et al. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. World J Surg 2001;25:259-65.
16. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 2002;90:897-903.
17. Freestone T, Turner RJ, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Artedoscler Thromb Vasc Biol 1995;15:1145-51.
18. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-26.
19. Knox JB, Sukhova GK, Whittemore AD, et al. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-12.
20. Tung WS, Lee JK, Tbompson RW. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 2001;34:143-50.
21. Petersen E, Gineitis A, Wagberg F, et al. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms: relation to size and rupture. Eur J Vasc Endovasc Surg 2000;20:457-61.
22. Petersen E, Wagberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg 2002;23:153-7.
23. Lindholt JS, Vammen S, Fasting H, et al. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms: a preliminary study. Eur J Vasc Endovasc Surg 2000;20:281-5.
24. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-7; discussion 127-9.
25. Zhang B, Dhillon S, Geary I, et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 2001;32:2198-202.
26. Wang J, Warzecha D, Wilcken D, et al. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci (Lond) 2001;101:87-92.
27. Tamarina NA, McMillan WD, Shively VP, et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-71; discussion 271-2.
28. Minematsu N, Nakamura H, Tateno H, et al. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001;289:116-9.
29. Yoon S, Tromp G, Vongpunsawad S, et al. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patienrs with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999;265:563-8.